Clinical trial
Natural Antioxidants in the Treatment of Multiple Sclerosis
NCT00010842 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00010842 |
|---|---|
| Title | Natural Antioxidants in the Treatment of Multiple Sclerosis |
| Official title | Natural Antioxidants in the Treatment of Multiple Sclerosis |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Ginkgo biloba, Alpha-lipoic acid, Vitamin E/Selenium, Essential fatty acids |
| Start date | Sep 1, 1999 |
| Completion | Dec 1, 2004 |
| First posted | Feb 5, 2001 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: